Urgent Need to Address Macrolide-resistant Mycoplasma Pneumoniae in Pediatric Populations: Insights from an Expert Consensus

Overview

Journal World J Pediatr

Specialty Pediatrics

Date 2024 Oct 4

PMID 39367166

Authors

Xiwei Wang

Wenwei Tu

Affiliations

Soon will be listed here.

Citing Articles

Urgent need to address macrolide-resistant Mycoplasma pneumoniae in pediatric populations: insights from an expert consensus.

Wang X, Tu W World J Pediatr. 2024; 20(10):981-982.

PMID: 39367166 DOI: 10.1007/s12519-024-00845-8.

References

Kim K, Jung S, Kim M, Park S, Yang H, Lee E . Global Trends in the Proportion of Macrolide-Resistant Mycoplasma pneumoniae Infections: A Systematic Review and Meta-analysis. JAMA Netw Open. 2022; 5(7):e2220949. PMC: 9274321. DOI: 10.1001/jamanetworkopen.2022.20949. View

Ding G, Zhang X, Vinturache A, van Rossum A, Yin Y, Zhang Y . Challenges in the treatment of pediatric Mycoplasma pneumoniae pneumonia. Eur J Pediatr. 2024; 183(7):3001-3011. DOI: 10.1007/s00431-024-05519-1. View

Wang X, Tu W . Urgent need to address macrolide-resistant Mycoplasma pneumoniae in pediatric populations: insights from an expert consensus. World J Pediatr. 2024; 20(10):981-982. DOI: 10.1007/s12519-024-00845-8. View

Matsuoka M, Narita M, Okazaki N, Ohya H, Yamazaki T, Ouchi K . Characterization and molecular analysis of macrolide-resistant Mycoplasma pneumoniae clinical isolates obtained in Japan. Antimicrob Agents Chemother. 2004; 48(12):4624-30. PMC: 529214. DOI: 10.1128/AAC.48.12.4624-4630.2004. View